PD-L1 >= 10% TIIC
About
Biomarker type: Protein expression
Marker: PD-L1
Unit: Tumor-infiltrating immune cells (TIIC)
Equality: >=
Value: 0.1
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | PD-L1 >= 10% TIIC | Non-Small Cell Lung Cancer | Atezolizumab | |
| HC (1) | PD-L1 >= 10% TIIC, Wild type ALK, Wild type EGFR | Non-Small Cell Lung Cancer | Atezolizumab |